Rebecca Auer, MD

Surgical Oncologist and Scientist, Ottawa Hospital Research Institute

[Rebecca Auer, MD @auer_r]

Thank you so much TOH/OHRI and uOttawa for the nomination. This is such an honour! 💕

[The Ottawa Hospital @OttawaHospital]

Congratulations Dr. Rebecca Auer on being recognized as one of 2024 @WXN Canada’s Most Powerful Women: Top 100 Award Winners! #WXNTop100

This year’s theme is #BeBold.

https://t.co/WdVaBkwgvO

[JAMA Surgery @JAMASurgery]

From @JAMA_current: Among patients undergoing liver resection for a cancer-related indication, tranexamic acid did not reduce bleeding or blood transfusion but increased perioperative complications. https://t.co/mNvn9x8De2

[Rebecca Auer, MD @auer_r]

@CathyEngMD @theNCI @VUMC_Cancer @VUMCDiscoveries Congratulations!! I love the message of perseverance. It’s so important to understand what it really takes!

[Rebecca Auer, MD @auer_r]

“Once you choose hope, anything is possible.” Christopher Reeve. I have repeated that to myself a thousand times. As doctors we always want to improve the outcome, and although sometimes we can’t, we can always affect the journey. Hope is key to every patient journey 💚

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

🌟 National Cancer Wellness Awareness Day 🌟

Today, we come together to raise awareness about the importance of #CancerWellness and the incredible support provided by cancer wellness centers and patient groups.

Cancer wellness is about nurturing #hope, building strength, and supporting overall well-being. These centers and groups play a vital role in helping individuals and their families navigate the challenges of cancer through comprehensive care and support programs.

At C3, we join efforts to grow #CCAHope among individuals affected by #cholangiocarcinoma by enhancing access to personalized testing, expert opinions, and treatments.

Read more about HOPE, and what we at C3 hope for.
#CancerWellness #BuildingHope #NurturingHope #CancerAwareness #SupportAndCare #NCWAD

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

Had a great meeting last night with 13 advocates discussing ways to mobilize and participate in advocacy for cholangiocarcinoma!

These meetings are co-hosted with Cholangio-Hepatocellularcarcinoma Canada + @curecc and happen every 2nd Wednesday of the month.

See you July 10!

[Rebecca Auer, MD @auer_r]

@LenetTori @uOttawaGenSurg @ASTSChimera Congrats Tori. That’s amazing!

[Rebecca Auer, MD @auer_r]

@OttMethodsCentr @OttawaCitizen Im so excited to be taking in this new role! Thanks you.

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

💚💚💚ALBERTA AGREES TO COVER PEMAZYRE FOR CHOLANGIOCARCINOMA 🙌🤝💪

#CCAHope #cholangiocarcinoma #Alberta #CancerTreatment #HealthcareVictory #AdvocacyWorks

https://t.co/1Aefoun2tj

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

We had our first meeting with @ccranorg about aligning on our common goals!

It's amazing to connect with GIANTS in the field of patient-focused cancer care and we are excited to attend their upcoming Biomarkers Conference on June 20-21st!

Registration is FREE & open to all

#biomarkers #moleculartesting

[Rebecca Auer, MD @auer_r]

@HalletJulie @mattgallowaycbc @SarooSharda_MD @TheCurrentCBC @CBC @UofTSurgery @UofTSurgOnc @uoftmedicine @Sunnybrook @ICESOntario Amazing work Julie and team!

[Julie Hallet @HalletJulie]

🎙️First in studio experience today joining @mattgallowaycbc to talk about team diversity in the operating room!
with input from @SarooSharda_MD

📻🎧Tune in @TheCurrentCBC to listen

Thanks for having me @CBC!

[Canadian Cancer Society @cancersociety]

On May 22 and 23, we gathered experts and people with cancer from across Canada for our Cancer Clinical Trials Forum. They met with politicians to talk about cancer treatment and innovation through clinical trials. Thanks to these committed Members of Parliament for leading this work!

We're so grateful for the collaboration through Canada’s first all-party federal cancer caucus at the House of Commons because cancer is an issue that affects ALL Canadians.

@DanAlbas @PeterSchiefke @morricemike @JeanYip3 @LailaGoodridge

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

Noor is one of MANY Canadians that are fighting for equitable access to life saving therapies.

@SpencerCTV updated us and @CTVKitchener news story about how Noor's case was brought to the House of Commons by @morricemike.

WATCH THE STORY HERE: https://t.co/XD7zdtbnb2

Thank you Noor for your bravery and action! You're giving #CCAhope to us all!

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

Without funding, Canadian patients have fallen behind the gold standard of care.

Read about Noor's fight - an issue many Canadians with CCA are facing - and sign the petition in the tweet below to stand with her and her family 💚 #CCAHope

https://t.co/YTVm7uN2c4

[Spencer Turcotte @SpencerCTV]

Ontario woman with incurable cancer pushing province to cover rare cancer drug | CTV News https://t.co/HH01ALOxsB

[Canadian Cholangiocarcinoma Collaborative 🍁💚 @c3_cholangio]

📢 Today in Parliament: Urgent discussions on ensuring #Pemazyre coverage for patients with FGFR2 fusion-driven cholangiocarcinoma. Access to life-saving treatments shouldn't be a privilege—it's a right. Let's support equitable healthcare for all! #HealthForAll #CancerTreatment #ParliamentSession #CCAHope🏛️💊

Link to video below!

Thank you @morricemike and @markhollandlib for discussing these issues for Noor and the many cholangiocarcinoma fighters who are in similar situations.

https://t.co/m2BrsSzED1

[Canadian Cancer Society @cancersociety]

On May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in OttawaOn May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in OttawaOn May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in OttawaOn May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in OttawaOn May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in OttawaOn May 22 & 23, we had the pleasure of bringing together the cancer community for our Cancer Clinical Trials Forum in Ottawa.

[Arndt Vogel @ArndtVogel]

Pertuzumab + Trastuzumab in Biliary Tract Cancer With ERBB2/3 Alterations
@JCO_ASCO
https://t.co/yUaeInmNPY
🔎 TAPUR phs 2
👉DC: 40%; ORR: 32%
👉PFS: 11; mOS 30 weeks
🧐Activity in pts w/ ERBB2/3 amplification, overexpression or mutations
@myESMO @EASLnews @ILCAnews @curecc #livertwitter

[Rebecca Auer, MD @auer_r]

@medoncdoc @_researchNS @cancercarens @NSHealthHub Congrats! That’s fantastic news!

[Arndt Vogel @ArndtVogel]

2nd line FOLFOX for biliary tract cancers pretreated with cisplatin/gemcitabine
@ESMO_Open
https://t.co/2E9esLIZWK
🔎systematic review & meta-analysis of 6 trials
👉ORR 10%, DCR 50%, mPFS 3mo, mOS 6,5 mo
🤨Hmm, we need to do better...
@myESMO @ILCAnews @EASLnews #livertwitter